Photoacoustic molecular imaging

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 6437, Issue , 2007, Pages

  Kiser Jr , William L ^a   Reinecke, Daniel ^b   Degrado, Timothy ^c   Bhattacharyya, Sibaprasad ^c   Kruger, Robert A ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b OptoSonics Inc   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Herceptin; Molecular imaging; Photoacoustic imaging; Targeted contrast agent

Indexed keywords

BREAST CANCER; HERCEPTIN; MONOCLONAL ANTIBODY; OPTICAL IMAGING; PHOTOACOUSTIC MOLECULAR IMAGING;

ANTIBODIES; BIOMIMETIC MATERIALS; MEDICAL IMAGING; METHANOL; TUMORS;

ACOUSTIC IMAGING;

EID: 34247367695     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.705136     Document Type: Conference Paper

References (36)

1. Y. Xu and L.-H. Wang, (2006) Rhesus monkey brain imaging through intact skull with thermoacoustic tomography, IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control 53 (3), 542-548.
2. X. Wang, X. Xie, G. Ku, G. Stoica, and L.-H. Wang, (2006) Non-invasive imaging of hemoglobin concentration and oxygenation in the rat brain using high-resolution photoacoustic tomography, Journal of Biomedical Optics 11 (2), 024015
3. R. A. Kruger, P-Y Liu and Y. Fang (1995). Thermoacoustic Ultrasound (PAUS) - reconstruction tomography. Medical Physics 22:1605-1609.
4. A. A. Oraevsky, R. O. Esenaliev, S. L. Jacques, S. K. Tittel (1996). Laser opto-acoustic tomography for medical diagnostics: principles. Proc. SPIE, 2976:22-31.
5. A. A. Oraevsky, V. G. Andreev, A. A. Karabutov, R. O. Esenaliev (1999). Two-dimensional optoacoustic tomography: array transducers and image reconstruction algorithm. Proc. SPIE 3601, 256-267
6. A. A. Oraevsky, A. A. Karabutov, V. G. Andreev, R. O. Esenaliev (1999). Laser opto-acoustic imaging of the breast: detection of cancer angiogenesis. Proc. SPIE, 3597:352-363.
7. R. A. Kruger, W. L Kiser Jr., D. R. Reinecke, G. A. Kruger GA (1999). Thermoacoustic computed tomography - technical considerations. Medical Physics, 26:1832-1837.
8. R. A. Kruger, W. L. Kiser Jr., D. R. Reinecke, G. A. Kruger, R. L. Eisenhart (1999). Thermoacoustic computed tomography of the breast at 434 MHz. Proc. IEEE, MTT-S:591-594.
9. R. A. Kruger, W. L. Kiser Jr., K. D. Miller, H. E. Reynolds (2000). Thermoacoustic CT scanner for breast imaging: design considerations. Proc. SPIE, 3982:354-359.
10. R. A. Kruger, W. L. Kiser Jr, K. D. Miller, H. E. Reynolds (2000). Thermoacoustic CT: imaging principles. Proc SPIE, 3916:150-159.
11. R. A. Kruger, K. D. Miller, H. E. Reynolds, W. L. Kiser Jr, D. R. Reinecke, G. A. Kruger (2000). Contrast enhancement of breast cancer in vivo using thermoacoustic CT at 434 MHz. Radiology 216:279-283.
12. R. A. Kruger and W. L. Kiser Jr (2001). Thermoacoustic CT of the breast: pilot study observations. Proc. SPIE, 4256:1-5.
13. R. A. Kruger, K. Stantz, W. L. Kiser Jr (2002). Thermoacoustic CT of the breast. Proc. SPIE, 4682:521-525.
14. Kruger RA, Kiser Jr WL, Reinecke DR, Kruger GA. Thermoacoustic Computed Tomography using a conventional linear transducer array. Medical Physics 2003;30(5):856-860.
15. Wang, S, et. al. Targeting HER2: Recent Developments and Future Directions for Breast Cancer. Seminars in Oncology 28(6) Suppl 18 (December); 2001, 21-29.
16. Hynes NE, Stern DF. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochimica et Biophysica Acta 1198; 1994, 165-184.
17. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human Breast Cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235; 1987, 177-182.
18. Venter DJ, Tuzi NL, Kumar S, Gullick WJ. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas; Immunohistological assessment correlates with gene amplification. Lancet. 2; 1987; 69-72.
19. Yarden Y, Biology of HER2 and Its importance in Breast Cancer. Oncology 61(suppl 2); 2001,1-13.
20. Wang SC, ZHang L, Hortobagyi GN, Hung MC. Targeting HER2: Recent Developments and Future Directions for Breast Cancer Patients. Seminars in Oncology 28(6) Suppl 18 (December); 2001, 21-29.
21. Lewis R. Herceptin Earns Recognition in Breast Cancer Arsenal. The Scientist 15[9]:10, Apr. 30, 2001.
22. Experts debate value of HER2 Testing Methods, Journal of the national Cancer Institute 92(4), February 16, 2000.
23. van de Vijver, M. Emerging Technologies for HER2 Testing. Oncology 63 (suppl 1); 2002; 33-38.
24. Press MF, Slamon DJ, Flom KJ, Park J, Zhou JY, Bernstein L. Evaluation of HER2/neu Gene Amplification and Overexpression: Comparison of Frequently Used Assay Methods in a Molecularly Characterized Cohort of Breast Cancer Specimens. J Clin Oncol 20(14) 2002; 3095-3105.
25. Hanna WM, Kahn HJ, Pienkowska M, Blondal J, Seth A, Marks A. Defining a Test for HER-2/neu Evaluation in Breast Cancer in the Diagnostic Setting. Mod Pathol 14(7); 2001; 677-685.
26. Pauletti G, Godolphin W, Press MF, Slamon DJ. Detection and quantification of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene. 13; 1996, 63-72.
27. Perez EA, Roche PC, Jenkins RB, Reynolds CA, Hailing KC, Ingle JN, Wold, LE. HER2 Testing in Pateinets with Breast Cancer: Poor Correlation Between Weak Immunohistochemistry and Gene Amplification by Fluorescence In Situ Hybridization. Mayo Clin Proc. 77; 2002, 148-154.
28. Bartlett JMS, Going JJ, Mallon EA, Watters AD, Reeves JR, Stanton P, Richmond J, Donald B, Ferrier R, Cooke TG. Evaluating HER2 amplification and over expression in breast cancer. J Pathol 195; 2001, 422-428.
29. Venter DJ, Kumar S, Tuzi NL, Gullick WJ. Overexpression of the c-erb-2 Oncoprotein in Human Breast Carcinomas: Immunohistological assessment Correlates With Gene Amplification. The Lancet, July 11, 1987: 69-72.
30. VanVeen RLP, Sterenborg HJCM, Marinelli, et al. J. Biomed. Optics. 2004;9(6):1129-1136.
31. Manohar S., Kharine A. van Hespen JCG, et al. J. Biomed. Optics. 2004;9(6):1172-1181.
32. Spinelli L, Torricelli A, Pifferi A, and Taroni P. J. Biomed. Optics. 2004;9(6):1137-1142.
33. van Staveren HG, Moes CJM, van Marie J, et al. "Light scattering in Intralipid-10% in the wavelength range of 400-1100 nanometers," Applied Optics 1991;30:4507-4514.
34. http://omlc.ogi.edu/spectra/intralipid/index.html.
35. Zhang LS, Zhang L, Zhang CP, et al. Measurements of absorption and anisotropy coefficients of the fat emulsion Intralipid-10%. Chin. Phys. Lett. 2004;21(12):2517-2520.
36. Royston DD, Poston RS and Prahl S. Optical properties of scattering and absorbing materials used in the development of optical phantoms at 1064 nm. J. Biomed. Optics. 1996;1(1):110-116.